Understanding ALG1L2: A Potential Drug Target Or Biomarker (G644974)

Target Name: ALG1L2

NCBI ID: G644974

ALG1L2

Other Name(s): AG1L2_HUMAN | asparagine-linked glycosylation 1-like 2 | putative glycosyltransferase ALG1L2 | ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase like 2 | Putative glycosyltransferase ALG1L2

Understanding ALG1L2: A Potential Drug Target Or Biomarker

ALG1L2 (AG1L2_HUMAN), a protein that belongs to the ALG family and is expressed in various tissues of the human body, including the brain, heart, and muscle, has been identified as a potential drug target or biomarker. Its function in these processes is not well understood, but research has shown that it plays an important role in several cellular processes, including cell adhesion, migration, and signaling.

One of the key functions of ALG1L2 is its role in cell adhesion. This protein is known to be involved in the formation of tight junctions, which are specialized barriers that help to maintain the integrity of tissues and are critical for various physiological processes, including cell signaling and isolation.

In addition to its role in cell adhesion, ALG1L2 has also been shown to be involved in the regulation of cell migration. This protein has been shown to play a role in the migration of neurons and other cells, including the regulation of the decision to move or stay in place. This process is critical for the development and maintenance of neural circuits and is a key factor in the development of neurodegenerative diseases.

Another function of ALG1L2 is its role in cell signaling. This protein has been shown to play a role in the regulation of several signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival and is a key factor in the development and maintenance of tissues and organs.

In addition to its role in cell signaling, ALG1L2 has also been shown to play a role in the regulation of inflammation. This protein has been shown to be involved in the regulation of the immune response and has been shown to play a role in the regulation of inflammation that can contribute to the development of inflammatory diseases.

Overall, while more research is needed to fully understand the functions of ALG1L2, it is clear that this protein plays an important role in several cellular processes that are critical for the development and maintenance of tissues and organs. As such, ALG1L2 is a potential drug target or biomarker that could be targeted by researchers to develop new treatments for a variety of diseases.

Protein Name: ALG1 Chitobiosyldiphosphodolichol Beta-mannosyltransferase Like 2

Functions: Putative glycosyltransferase

The "ALG1L2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ALG1L2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets